Fortitude Family Office »

Regeneron Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-12-31 $39k 54 712.33
2024-09-30 $59k 56 1051.23
2024-06-30 $59k 56 1051.04
2024-03-31 $34k 35 962.49
2023-12-31 $31k 35 878.29

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Vanguard Mid-cap Etf Etf (VO)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Tips Bond Etf Etf (TIP)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Avantis International Small Cap Value Etf Etf (AVDV)
Kkr & Co Stock (KKR)

View all positions for Fortitude Family Office

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
FMR
Jpmorgan Chase & Co
State Street Corporation
Capital Research and Management Company - Division 3
Capital World Investors
Geode Capital Management
Dodge & Cox
T. Rowe Price Associates
Franklin Resources
Loomis, Sayles and
Amundi
Morgan Stanley
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals